000 | 01601 a2200457 4500 | ||
---|---|---|---|
005 | 20250514051723.0 | ||
264 | 0 | _c20030106 | |
008 | 200301s 0 0 eng d | ||
022 | _a0003-4967 | ||
024 | 7 |
_a10.1136/ard.61.12.1060 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avan Ede, A E | |
245 | 0 | 0 |
_aPurine enzymes in patients with rheumatoid arthritis treated with methotrexate. _h[electronic resource] |
260 |
_bAnnals of the rheumatic diseases _cDec 2002 |
||
300 |
_a1060-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenosine Deaminase _xdrug effects |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
650 | 0 | 4 | _aBlood Sedimentation |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFolic Acid _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoxanthine Phosphoribosyltransferase _xdrug effects |
650 | 0 | 4 |
_aLeucovorin _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethotrexate _xadverse effects |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNucleotidases _xdrug effects |
650 | 0 | 4 |
_aPurine-Nucleoside Phosphorylase _xdrug effects |
650 | 0 | 4 |
_aPurines _xmetabolism |
650 | 0 | 4 | _aRegression Analysis |
700 | 1 | _aLaan, R F J M | |
700 | 1 | _aDe Abreu, R A | |
700 | 1 | _aStegeman, A B J | |
700 | 1 | _avan de Putte, L B A | |
773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 61 _gno. 12 _gp. 1060-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.61.12.1060 _zAvailable from publisher's website |
999 |
_c12236642 _d12236642 |